The answer changes with the question. Compare human-trial activity under explicitly different denominators.
95% Wilson interval: 83.4%–90.5%. Derived from the any-trial flag on ChEMBL-resolved records.
95% Wilson interval: 7.4%–13.9%. Stringent aggregate count for acute-injury trials.
95% Wilson interval: 84.1%–89.3%. Derived from the any-trial flag on ChEMBL-resolved records.
95% Wilson interval: 8.3%–13.0%. Stringent aggregate count for acute-injury trials.
Prevention and treatment of haemorrhage/fibrinolytic bleeding (surgical bleeding, cyclic heavy menstrual bleeding, haemophilia dental extraction); antifibrinolytic (approved 1986)
Approved for trauma (caveats)Bone regeneration: anterior lumbar interbody spinal fusion (2002) and acute open tibial shaft fractures (2004); dibotermin alfa (InFUSE/Inductos)
Approved for trauma